Using 3D models to improve surgery for children's pelvic and retroperitoneal tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of automatically generated 3D models of tumors to traditional 2D images in aiding surgical planning for pediatric patients. Parents, patients, and surgical teams will evaluate the 3D models against standard 2D images through questionnaires. The study aims to enhance understanding and communication regarding tumor characteristics before surgery, utilizing MRI and CT scans as part of routine care. The focus is on children with pelvic or retroperitoneal tumors who require imaging prior to surgical intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Children:

* Children between 3 months and less than 18 years old
* Children with a pelvic tumor requiring an MRI for a possible surgical intervention
* Children with a retroperitoneal tumor requiring a CT scan or MRI with a view to surgical intervention
* Children with no contraindication for a CT scan and/or 3T MRI
* Children whose parents do not object to their participation in the study

Other participants:

* Operating surgeon agreeing to participate in the study
* Caregiver agreeing to participate in the study
* External surgeon agreeing to participate in the study

Exclusion Criteria:

Children :

* Contraindication to MRI: metallic ocular foreign body, pacemaker, mechanical heart valve, old vascular clips on cerebral aneurysm
* Need for an MRI under general anaesthesia
* Contraindication for a CT scan with injection: renal failure, allergy to iodinated contrast products
* Patients having participated in a therapeutic clinical trial involving a new molecule within 30 days before inclusion
* Emergency situation

Where it's running

• Hôpital Necker Enfants Malades. Service de Chirurgie Viscérale et Urologie pédiatrique
  Paris, Île-de-France Region, France Recruiting

Study contacts

• Study coordinator: Thomas BLANC, MD
• Email: thomas.blanc@aphp.fr
• Phone: +33 1 44 49 41 53

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Daily adjustment of radiation dose in MRI-guided SBRT for abdominal and pelvic tumors

  This trial tests whether adjusting the radiation dose in real-time during MRI-guided SBRT improves targeting for abdominal or pelvic tumors.

  Recruiting University of Zurich · Zurich, Canton of Zurich · NCT07687147

• Registry for Online Adaptive Radiotherapy in Pelvic and Thoracic Tumors

  This study is testing if a new type of radiotherapy that adapts to patients' changing needs can reduce side effects and improve outcomes for people with pelvic or thoracic tumors compared to standard treatment.

  Recruiting University Medical Center Goettingen · Göttingen · NCT06185062

• Diffusion MRI to map nerve lesions in obstetric brachial plexus palsy

  This study tests diffusion MRI and tractography to better understand nerve injuries in people with obstetric brachial plexus palsy.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07767708

• Long-term心理 and cognitive check after stem cell transplant for immune deficiencies

  This study tests the long-term neurocognitive and psychological functioning of 6–8 year-old children who had an allogeneic stem cell transplant for a primary immune deficiency, at least two years after the transplant.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07766304

• Benchmarking AI language models against tumor boards for oncology treatment decisions

  This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.

  Recruiting Assistance Publique - Hôpitaux de Paris · Boulogne-Billancourt and 4 other locations · NCT07739121

• Gut microbes and autoinflammatory diseases: how they may be linked

  This study tests whether gut bacteria and their byproducts relate to digestive and inflammatory symptoms in people with autoinflammatory diseases.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07718555

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.